Consolidated Statements of Cash Flows (USD $)	12 Months Ended
	Sep. 29, 2012	Oct. 01, 2011	Oct. 02, 2010
OPERATING ACTIVITIES:
Net income	$ 5,214,973	$ 3,699,066	$ 4,506,215
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	756,656	720,478	743,158
Amortization	452,670	89,218	70,133
Provision for losses on accounts receivable	32,008	36,936	26,868
Provision (Benefit) for deferred income taxes	(66,000)	164,000	455,095
Gain on sale and disposal of property and equipment			(17,902)
Increase in cash value of life insurance	(194,806)	(11,848)	(106,807)
Deferred compensation	(54,705)	(51,626)	(47,803)
Stock compensation expense	72,264	69,497	18,936
Changes in operating assets and liabilities:
Accounts receivable	(69,307)	741,736	(848,462)
Inventories	520,981	(3,534,362)	(226,061)
Prepaid expenses and other assets	256,544	441,060	(375,195)
Accounts payable and accrued and sundry liabilities	(55,964)	633,221	(440,590)
Net cash provided by operating activities	6,865,314	2,997,376	3,757,585
INVESTING ACTIVITIES:
Acquisition of M.C. Healthcare	(8,251,831)
Purchases of securities available for sale		(2,760,000)	(1,700,000)
Proceeds from sale of securities available for sale	4,000,000	2,460,000	1,700,000
Purchases of property and equipment	(684,327)	(191,209)	(270,576)
Proceeds from sale of property and equipment			19,500
Payments for other assets	(107,528)	(102,665)	(68,957)
Net cash used for investing activities	(5,043,686)	(593,874)	(320,033)
FINANCING ACTIVITIES:
Dividends paid	(1,358,425)	(1,166,789)	(3,856,477)
Proceeds from long-term debt	9,300,000
Repayment of long-term debt	(9,300,000)
Purchase and retirement of common stock		(8,292)	(346,234)
Proceeds from exercise of options for common stock	68,946	114,790	282,410
Net cash used for financing activities	(1,289,479)	(1,060,291)	(3,920,301)
Effect of exchange rates on cash	8,747
Increase (Decrease) in cash and cash equivalents	540,896	1,343,211	(482,749)
Cash and cash equivalents at beginning of year	2,124,406	781,195	1,263,944
Cash and cash equivalents at end of year	$ 2,665,302	$ 2,124,406	$ 781,195